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Background: Radiotherapy (RT) of the neck is commonly given to nasopharyngeal carcinoma (NPC) patients for
preventing cervical lymph node metastasis. However, neck RT may induce the development of carotid atherosclerosis.
The mechanisms of radiation-induced carotid atherosclerosis are still unclear and no previous study has investigated
the genetic involvement of radiation-induced carotid atherosclerosis. The present study aims to determine the
association between genetic polymorphisms and carotid atherosclerosis in patients treated with RT for nasopharyngeal
carcinoma.
Methods: The present study recruited 128 post-RT NPC patients. Carotid plaque score was assessed using
ultrasonography. Thirteen single nucleotide polymorphisms (SNPs) that affect the function of anti-atherosclerotic genes,
including SOD2, SOD3, CAT, PON1, PPARG, ADIPOQ, IL10, TGFB1 and NOS3, were genotyped. Association between the 13
SNPs and carotid atherosclerosis was evaluated using multiple regression after adjustment for covariates (PLINK).
Multiple testing was corrected using Benjamini-Hochberg step-up false discovery rate controlling procedure.
Results: rs662 and rs705379 of PON1 were close to be significantly associated with carotid plaque score (Corrected
P value, Pcor = 0.0528 and Pcor = 0.0842). When the two SNPs were combined together, TC haplotype in rs662-rs705379
of PON1 was significantly associated with higher carotid plaque score (Pcor < 0.05). None of the other SNPs showed
significant association with carotid plaque score.
Conclusions: TC haplotype in rs662-rs705379 of PON1 is likely to be a genetic risk factor of carotid plaque score.
Post-RT NPC patients with the TC haplotype may need earlier and more frequent carotid ultrasound examinations for
early detection of carotid atherosclerosis.
Keywords: Radiation, Nasopharyngeal carcinoma, Carotid atherosclerosis, Carotid plaque score, Single nucleotide
polymorphisms, ParaoxonaseBackground
Nasopharyngeal carcinoma (NPC) is a common head
and neck malignancy in Southeast Asia and Southern
China [1]. Radiotherapy (RT) is the standard strategy for
treating nasopharyngeal carcinoma (NPC). Owing to the
high prevalence of cervical lymph node metastasis in
NPC patients, RT of the neck is usually given to the
patients for preventing or treating the nodal metastasis
[2]. However, ionizing radiation in neck RT damages the* Correspondence: htmying@polyu.edu.hk
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unless otherwise stated.carotid artery and may induce carotid atherosclerosis,
which may lead to cerebrovascular events [3-6].
The mechanisms of radiation-induced carotid athero-
sclerosis are still unknown. However, the mechanisms of
spontaneous atherosclerosis are well established, which
provide baseline information for the understanding of
the mechanisms of radiation-induced carotid atheroscler-
osis. Different pathways in the regulation of oxidative
stress, lipid metabolisms, and inflammation may protect
the carotid artery from atherosclerosis. There are many
genes whose encoded proteins are involved in these pro-
tective pathways. Superoxide dismutases (SODs) are the
primary enzymes in the defense of oxidative stress, whichhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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hydrogen peroxide (H2O2) [7]. Catalase (CAT) further
scavenges the toxic H2O2 by converting it into water
(H2O) and molecular oxygen (O2) [8]. Paraoxonase 1
(PON1) prevents the oxidation of low intensity lipoprotein
(LDL), and inhibits the uptake of oxidized LDL by and
cholesterol synthesis in macrophages [9]. Peroxisome
proliferators-activated receptor γ (PPARG) is a pivotal
nuclear receptor that regulates the expression of genes in-
volved in lipid metabolisms and inflammatory responses
[10]. Adiponectin (ADIPOQ) suppresses the inflammatory
responses and the uptake of oxLDL by macrophages [11].
Interleukin-10 (IL10) and transforming growth factor-β1
(TGFB1) are the most important anti-inflammatory cyto-
kines in immune cells [12,13]. Endothelial nitric oxide
synthase (NOS3) catalyzes the production of nitric oxide,
which prevents platelet aggregation, adhesion molecule
expression in endothelial cells and vascular SMC prolifer-
ation [14].
Some single nucleotide polymorphisms (SNPs) that
affect the expression of these genes (SOD2, SOD3, CAT,
PON1, PPARG, ADIPOQ, IL10, TGFB1 and NOS3) and/
or the functions of their corresponding proteins have
been shown to be associated with spontaneous athero-
sclerosis [15-24]. However, the association of these SNPs
with radiation-induced carotid atherosclerosis is still
unknown. Therefore, the present study was under-
taken to investigate the association between the SNPs
in these nine genes and the severity of carotid athero-
sclerosis in post-RT NPC patients. The findings will
offer potential genetic markers of radiation-induced
carotid atherosclerosis, which might facilitate the selection
of high-risk patients with carotid atherosclerosis so
that timely diagnosis and treatment can be given to the
patients.
Methods
Subjects
Post-RT NPC patients were recruited from the Department
of Clinical Oncology of Queen Mary Hospital from
March 2013 to March 2014. The inclusion criteria of
subjects were local residents, Han Chinese NPC pa-
tients, older than 18 years, and completed RT for at
least four years, whilst the exclusion criteria of subjects
were more than one course of RT, history of carotid ath-
erosclerosis prior to RT, previous carotid endarterec-
tomy and carotid stenting.
This study was approved by the Human Subject Ethics
Subcommittee of the Hong Kong Polytechnic University
and the Institutional Review Board of the University of
Hong Kong/Hospital Authority Hong Kong West Cluster.
Written consent was obtained from all patients before
the commencement of the interview and ultrasound
examination.Clinical information
Archived clinical records were reviewed and individual
face-to-face interviews were conducted. The information
of post-RT duration, radiation dose, chemotherapy and
history of carotid atherosclerosis was obtained from ar-
chived clinical records. The presence of cardiovascular
risk factors was identified as follows: 1) DM, diagnosed
with DM in the clinical record, taking medications to
lower blood glucose and/or fasting plasma (blood) glu-
cose ≥ 7.0 (6.1) mmol/L [25]; 2) hypertension, diagnosed
with hypertension in the clinical record, undergoing
anti-hypertensive medications and/or the measured
blood pressure ≥ 140/90 mmHg [26]; 3) hypercholesterol-
emia, diagnosed with hypercholesterolemia in the clinical
record, undergoing medications to lower the cholesterol
level and/or fasting total cholesterol ≥ 5.2 mmol/L [27]; 4)
CHD, diagnosed with coronary vascular disease in the
clinical record and/or had coronary stenting [28]; 5)
smoking, current smoker consuming 10 cigarettes per day
for at least six months [28].
Selecting and genotyping of SNPs
A literature research was performed for the selection of
candidate genes and relevant SNPs in the present study
(Pubmed). Candidate genes involving oxidative stress,
lipid metabolism and inflammation and having association
with atherosclerosis were reviewed. Only the genes, in
which SNPs influence the expression of these genes or the
function of the encoded proteins, and have minor allele
frequency > 0.1 in Han Chinese and evidences for associ-
ation with spontaneous atherosclerosis, including carotid
atherosclerosis, coronary atherosclerosis, and ischemic
cardiovascular and cerebrovascular diseases, were selec-
ted. In total, 13 SNPs in the 9 genes, SOD2, SOD3, CAT,
PON1, PPARG, ADIPOQ, IL10, TGFB1 and NOS3, were
included in the present study (Table 1) [15-24]. Genomic
DNA was extracted from 6 ml of peripheral blood for
genotyping. Restriction fragment length polymorphism
(RFLP) and unlabeled probe melting analysis (UPMA)
were used for genotyping as described previously [29-31].
The primers and probes used in genotyping are shown in
Table 1.
Ultrasound examinations
Carotid ultrasound examinations were performed in a
22°C air-conditioned examination room using the Esaote
MyLab Twice ultrasound unit in conjunction with a
4–13 MHz linear transducer (Esaote, Genoa, Italy).
Subjects lied supine on the examination couch with the
neck slightly extended and the head turned away from
the side under examination. Using gray-scale ultrasound,
the extra-cranial carotid artery was screened longitudinally
and transversely. Carotid plaque was identified as a focal
thickening >50% of the adjacent intima-media layer [32].
Table 1 Primers and probes in genotyping
Genes SNPs Forward primers Reward primers Probes Genotyping
methods
SOD2 rs4880 CCA GCC TGC GTA GAC GGT CGT GGT GCT TGC TGT GGT G AGC CCA GAT ACC CCA AAG
CCG GAG CCA Gaa
UPMA
SOD3 rs2536512 AGG ACT CAG CGG AGC CCA ACT 18 T + TTG GCA CGG GAC GCA AGC TG - RFLP (BstUI)
CAT rs769217 TGT TAC CGC CCC TAG TCA GTG TC CAC CTC GGG AGC ACC TTT ACC A - RFLP (BstXI)
PON1 rs662 10 T + GAA TGA TAT TGT TGC
TGT GGG ACC TGA G
CCA TCG GGT GAA CTG TTG ATT
CCA TTA G
- RFLP (MboI)
rs705379 AAA TGG GAC TTT TGG CTG A ACA CTG ACG GGC TAG GA CGC CGA TTT GCC CGC CCC
GCC CCT CCC Caa ta
UPMA
PPARG rs3856806 GCT GAA CCA TCC TGA GTC CTC 33 T + TGG AAG AAG GGA CAT GTT GGC - RFLP (NspI)
ADIPOQ rs1501299 CAC CGA CAG AGC CTT GCA
CAT TAG
GGG GGT CTG CAC AGG TTG GAT G - RFLP (BsmI)
rs2241766 15 T + GAT GCT GTT GCT GGG
AGC TGT
30 T + CCC GAG A CGC CAT CCA ACC
TGT GC
- RFLP (AvaI)
IL10 rs1800872 GGA GCC TGG AAC ACA TCC TG AAA TGA GGG GGT GGG CTA AAT ATC ACC CCC CCT GTC CTG TAG
GAA GCC AGt CTa ata
UPMA
TGFB1 rs1800469 TGA CCC CAG CTA AGG CAT G TTT TTC CTC TTC TCC CGA CCA G - RFLP (Eco81I)
rs1800470 TCA CCA GCT CCA TGT CGA TA ATC CCT GTT CGC GCT CTC CAG CAG CGG TAG CAG CAG
CGG CAG CAG Caa
UPMA
rs4803455 TCA CTG CAA CCT CTG TGT CTT 20 T + CTG CAT ATT TGA CAC CCT GTA TT - RFLP (TasI)
NOS3 rs1799983 ACC CCA GAA AAC GGT CGC TTC G CCC CGA TTT CCA GCA GCA TGT TG - RFLP (MboI)
UPMA, unlabeled probe melting analysis; RFLP, restriction fragment length polymorphism.
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images of the plaque were obtained and the degree of
carotid stenosis was expressed as a percentage reduction
of the lumen diameter at the most stenotic site. Carotid
plaque score was evaluated using an adjusted plaque scor-
ing system [28]. In the scoring system, the carotid artery
was divided into five segments: 1. Proximal common ca-
rotid artery (≥2 cm proximal to carotid bifurcation); 2.
Distal common carotid artery (<2 cm proximal to carotid
bifurcation); 3. Carotid bulb and bifurcation; 4. Internal
carotid artery; and 5. External carotid artery. The degree
of carotid stenosis in each segment was measured and
carotid plaque score was expressed as the summation of
the degree of carotid stenosis of all segments in both
carotid arteries (Figure 1).
Statistical analysis
Data of carotid plaque score was transformed loga-
rithmically because it was not normally distributed.
Testing of genotypes for Hardy-Weinberg equilibrium
(HWE) in all subjects was determined by exact test as
executed in PLINK (version 1.07, [33]). The threshold
for significant deviation from HWE was set as 0.01
[34]. Only markers fulfilling HWE were included in
association analyses.
In the potential covariates, such as age, gender, radiation
dose, chemotherapy, post-RT duration and cardiovascular
risk factors, the significant predictors in regression models
were adjusted in association analyses. Linear regressionexecuted in PLINK was used for assessing the association
between single SNP and carotid plaque score with adjust-
ment for post-RT duration and number of cardiovascular
risk factors (significant predictors in regression models).
The regression analysis was performed under additive,
dominant or recessive models. FDR correction was used
for correcting multiple testing. Pcor < 0.05 was considered
as significant for association analysis.
Three genes, PON1, ADIPOQ and TGFB1, had more
than one SNP examined in the present study. The haplo-
types in each of these three genes were determined
for the association with carotid plaque score in post-
RT NPC patients. Sliding window (2 or 3 SNPs per
window) using linear regression in PLINK was uti-
lized for the association analysis with adjustment for
post-RT duration and number of cardiovascular risk
factors. FDR correction was also used for correcting
multiple testing. Linkage disequilibrium (LD) statistics
D’ and r2 in paired SNPs were calculated using Pairwise
LD in PLINK. Pcor < 0.05 was considered as significant for
association analysis.
Results
Demographic information
A total of 128 post-RT NPC patients were included in
the present study. All patients were treated conventional
2D RT of the neck. The mean age of the patients was
55.2 ± 8.8 years with a range of 33 to 86 years. There
were 86 males and 42 females. The mean radiation dose
Figure 1 Assessment of carotid plaque score. A). Five segments
of the extra-cranial carotid artery: 1. proximal common carotid artery
(≥2 cm proximal to carotid bifurcation); 2. distal common carotid
artery (<2 cm proximal to carotid bifurcation); 3. carotid bulb and
bifurcation; 4. internal carotid artery; and 5. external carotid artery.
B). A longitudinal gray-scale image of a carotid plaque in the distal
common carotid artery. C). A transverse gray-scale ultrasound image
of the carotid plaque in B. The degree of the carotid stenosis is
expressed as the percentage reduction of lumen diameter (1-D1/D2 =
41.3%). Carotid plaque score is the summation of the degree of carotid
stenosis of the five segments in both carotid arteries.
Table 2 Demographic information of post-RT NPC patients
Parameters Total n = 128
Age, years 55.2 ± 8.8
Gender (female/male), n 42/86
Chemotherapy, n (%) 63 (49.2%)
Radiation dose, Gy 66.82 ± 3.20
Post-RT duration, years 12.6 ± 6.0
Hypercholesterolemia, n (%) 39 (30.5%)
Hypertension, n (%) 35 (27.3%)
Diabetes mellitus, n (%) 14 (10.9%)
Current smoker, n (%) 5 (3.9%)
Coronary heart disease, n (%) 5 (3.9%)
Stroke or transient ischemia attack, n (%) 7 (5.5%)
Presence of carotid plaque, n (%) 114 (89.1%)
Carotid plaque score 1.41 ± 1.37
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Of the 128 patients, 63 were also treated with chemother-
apy. The mean post-RT duration was 12.8 ± 6.0 years with
a range of 4 to 37 years. The most common cardiovascularrisk factor was hypercholesterolemia (n = 39), followed by
hypertension (n = 35) and then by DM (n = 14). Only 5
patients were current smoker, and 5 patients had CHD
and 7 patients developed stroke or transient ischemia
attack (Table 2).
Association analysis
Genotype proportions were all in HWE for 13 SNPs
(P > 0.01, Table 3). In the 13 SNPs, only rs662 and
rs705379 in PON1 were close to be significantly asso-
ciated with carotid plaque score in post-RT NPC
patients (rs662, Pcor = 0.0842 in additive model and
Pcor =0.0528 in dominant model; and rs705379, Pcor =
0.0842 in additive and dominant models, Table 3). T
allele of rs662 and C allele of rs705379 were the risk
alleles for higher carotid plaque score (rs662, TT + TC
vs CC: 1.76 ± 1.60 vs 1.07 ± 0.97; rs705379, TT + TC vs
CC: 1.22 ± 1.01 vs 1.79 ± 1.82). When the two SNPs
were combined, the haplotype window rs662-rs705379
in PON1 had a significant association with carotid
plaque score (Pcor < 0.05, Table 4). TC haplotype of rs662-
rs705379 posed a higher risk for higher carotid plaque score
(unstandardized coefficients = 0.0873, Pcor < 0.05). None of
other SNPs and haplotypes showed significant association
with carotid plaque score (Pcor > 0.05, Tables 3 and 4).
Discussion
Carotid atherosclerosis is a common complication in
post-RT NPC patients. However, the mechanisms of
radiation-induced carotid atherosclerosis are still unclear
and no previous study has reported the association
between genetic polymorphisms and radiation-induced
carotid atherosclerosis. The present study comprehensively
investigated the association between 13 SNPs in anti-
atherosclerotic genes and radiation-induced carotid ath-
erosclerosis. Results showed that SNPs in PON1 tended to
Table 3 Genotypes, minor allele frequency, Hardy-Weinberg Equilibrium and single-marker association analysis in all
selected SNPs
Genes SNPs Allelesa (1/2) Genotypes
(11/12/22)
MAF HWE Corrected P valuesb 1-β SS0.8
Additive Dominant Recessive
SOD2 rs4880 G/A 4/24/100 0.1250 0.1065 0.9588 0.9588 0.9588 0.0230 1371
SOD3 rs2536512 A/G 10/60/58 0.3125 0.4103 0.9588 0.9609 0.9588 0.0030 7785
CAT rs769217 T/C 29/69/30 0.4961 0.4792 0.9588 0.9657 0.9588 0.0040 5862
PON1 rs662 T/C 15/49/64 0.3086 0.2986 0.0842 0.0528 0.9588 0.5240 194
rs705379 T/C 35/49/44 0.4648 0.0124 0.0842 0.0842 0.4988 0.3020 283
PPARG rs3856806 T/C 8/43/77 0.2305 0.6168 0.9588 0.9588 0.9588 0.0130 2072
ADIPOQ rs1501299 T/G 8/56/64 0.2812 0.5107 0.9657 0.9588 0.9588 0.0030 8510
rs2241766 G/T 9/59/60 0.3008 0.3994 0.9657 0.9657 0.9588 0.0050 5443
IL10 rs1800872 G/T 17/47/64 0.3164 0.1012 0.8279 0.9588 0.5357 0.0660 684
TGFB1 rs1800469 G/A 20/61/47 0.3945 1 0.9588 0.9588 0.9588 0.0100 2632
rs1800470 A/G 21/61/46 0.4023 1 0.9588 0.9588 0.9588 0.0220 1404
rs4803455 A/C 20/50/58 0.3516 0.1203 0.9588 0.9588 0.9588 0.0080 3085
NOS3 rs1799983 T/G 1/29/98 0.1211 0.6926 0.9657 0.9813 0.9588 0.0040 5862
aAllele 1 is the minor allele and allele 2 is the major allele.
bCorrected P values after false discovery rate correction for multiple testing (including the 39 tests in the single-marker association analyses between the 13 SNPs
and carotid plaque score across the three genetic models).
Post-RT duration and number of cardiovascular risk factors were adjusted using linear regression in all association analyses. Statistical power (1-β) was calculated
using the model with smallest observed P value. SS0.8 was the sample size to achieve a statistical power of 0.8 in the corresponding analysis. MAF, minor allele
frequency; HWE, Hardy-Weinberg Equilibrium.
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post-RT NPC patients.
PON1 is one of the important enzymes for hydrolyzing
LDL oxidation, playing a pivotal role against carotid
atherosclerosis. The SNP rs662 (T > C) locating in the
coding region of PON1 gene replaces glutamine (Q) by
arginine (R) at codon 192 (Q192R). This variation affects
the activities of PON1 in the hydrolysis of different sub-
strates. The 192Q allozyme has higher hydrolytic activity
toward diazoxon, soman and sarin, while the 192R allo-
zyme is more efficient for hydrolyzing paraoxon and
fenitroxon [35,36]. Another important variation, rs705379,
is located at position −107 of the promoter region
(−107 T/C), which contributes to a decrease in the PON1
expression level and PON1 circulating concentration [37].
In the present study, significant observed P values
were found in the association analyses between carotid
plaque score and rs662 as well as rs705379 in additive
and dominant models (rs662, P = 0.0054 and 0.0014 re-
spectively; rs705379, P = 0.0077 and 0.0086 respectively).
The significant association failed to survive in the cor-
rection for multiple testing by FDR, but it was close to
be significant (Pcor = 0.0528 and 0.0842 respectively). In
the association analyses with rs662 and rs705379, the
statistical power was 0.524 and 0.302 respectively. To
achieve a statistical power of 0.8, at least 194 and 283
patients would be needed respectively. Therefore, small
sample size in the present study (n = 128) may account
for the non-significant findings. Future studies withlarger sample sizes are needed for investigating the associ-
ation. Nevertheless, the two SNPs had a cumulative effect
on carotid plaque score. Patients carrying T allele in rs662
(QR +QQ, n = 64) had 1.76 ± 1.60 of carotid plaque score,
whilst those with CC genotype in rs705379 (n = 44) had
1.79 ± 1.82 of carotid plaque score. In patients carrying
both T allele in rs662 and CC genotype in rs705379
(n = 38), the plaque score was 1.94 ± 1.89. TC haplo-
type in rs662-rs705379 showed significant association with
the plaque score after the correction for multiple testing
(Pcor = 0.0158). Thus, rs662 and rs70539 in combination
were more powerful to detect the association with carotid
plaque score in the present study. TC in rs662-rs705379
would be the risk haplotype for carotid plaque score in
post-RT NPC patients.
D’ and r2 of the two SNPs were 0.871 and 0.294
respectively. The high D’ indicated that the two SNPs
were in LD and were co-inherited most of the time.
However, the different frequencies of alleles in the two
SNPs (minor allele frequency = 0.3086 and 0.4648 respect-
ively) resulted in the low r2. Therefore, the two SNPs can-
not predict for each other.
In contrast to previous studies in which the R variant
of the Q192R polymorphism (C allele in rs662) was a risk
factor for spontaneous atherosclerosis diseases [21,38], the
present study found that the R variant would be protective
for radiation-induced carotid atherosclerosis. Patients car-
rying RR had lower plaque score as compared to those
with QR and QQ genotypes (RR vs QR+QQ: 1.07 ± 0.97
Table 4 Association analyses between haplotypes and
carotid plaque score in post-RT NPC patients
Genes D’ r2 Hap Freq Pcor 1-β SS0.8
PON1
rs662-rs705379 0.871 0.294 TC 0.290 0.0158 0.849 117
CT 0.446 0.1881
TT 0.019 0.6840
CC 0.245 0.9740
ADIPOQ
rs1501299- rs2241766 1 0.168 GG 0.301 0.9740 0.047 1047
TG 0.418 0.9740
TT 0.281 0.9740
TGFB1
rs4803455- rs1800470 0.88 0.628 CG 0.573 0.8766 0.033 1363
AA 0.326 0.8766
AG 0.025 0.8766
CA 0.076 0.9740
rs1800470-rs1800469 1 0.936 AG 0.391 0.8766 0.061 875
GA 0.594 0.8766
AA 0.012 0.9740
rs4803455-rs1800470-
rs1800469
0.883 0.648 AAG 0.322 0.8766 0.097 638
CGA 0.573 0.8766
CAG 0.069 0.9740
AGA 0.021 0.9740
Five haplotype windows (HWs) include rs662-rs705379, rs1501299-rs2241766,
rs4803455-rs1800470, rs1800470-rs1800469, and rs4803455-rs1800470-rs1800469.
Post-RT duration and number of cardiovascular risk factors were adjusted using
linear regression in all analyses. Multiple testing was corrected by false discovery
rate. Statistical power (1-β) was calculated using the model with smallest
observed P value. SS0.8 was the sample size to achieve a statistical power of 0.8 in
the corresponding analysis. Hap, haplotype; Freq, frequency; Pcor, Corrected P value.
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mented that RR and QQ allozymes serve anti-oxidant
activities in different stages based on different substrates
[39]. The various hydrolytic activities of R and Q allo-
zymes in PON1 for different substrates may account for
the conflicting results between the present and previous
studies. The oxidative condition in the irradiated cases
may be different from that in those without radiation
treatment. PON1 may protect LDL from oxidation by a
certain activity based on the different substrates in the
irradiated cases and the non-irradiated ones. Thus,
RR of Q192R polymorphism would be protective against
radiation-induced carotid atherosclerosis, although it may
be the risk of spontaneous atherosclerosis diseases.
Limitations
The present study was a cross-sectional investigation
with only 128 post-RT NPC patients and without a non-
irradiated control group. The study design and small
sample size limited the statistical power in associationanalyses. Thus, the potential association between some
SNPs and carotid plaque score in post-RT NPC patients,
and the potential interaction between the TC haplotype
and irradiation, may not be fully investigated. In
addition, the present study did not investigate the PON1
concentration and activity due to limited resources.
Whether the TC haplotype decreases the concentration
and activity of PON1 and consequently promotes the
plaque score in post-RT NPC patients remains to be
confirmed in future studies. Given that this study was an
exploratory investigation, and the sample size and study
design were limited, future investigations, especially pro-
spective studies, are suggested to investigate the role of
PON1 in the development of radiation-induced carotid
atherosclerosis and the effectiveness of using the TC
haplotype in the prevention of radiation-induced carotid
atherosclerosis.
Conclusion
TC haplotype in rs662-rs705379 of PON1 is likely to be
a genetic risk factor of carotid plaque score. The present
study provides preliminary finding of the association
between genetic polymorphisms with the radiation-
induced carotid atherosclerosis in post-RT NPC patients,
which facilitates the understanding of genetic markers for
the selection of NPC patients with high risk of carotid ath-
erosclerosis so as to conduct appropriate examinations for
early diagnosis and prompt treatment for carotid athero-
sclerosis in post-RT NPC patients.
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